nScrypt has partnered with the U.S. Military, the Uniformed Services University 4D Bio3 Program, and The Geneva Foundation to move bioprinting out of sterile biology laboratories to forward-deployed military positions. The Geneva Foundation is a 501(c)3 non-profit organization that advances military medicine through innovative scientific research, program management, and a dedication to U.S. service members and veterans, their families, and the global community.
For this project, nScrypt customized its BioAssembly Tool (BAT) bioprinter and created a light weight and ruggedized model, shrouding it in a protective local environment for bioprinting in challenging conditions. The research team will ship the ruggedized bioprinter (also called an “austere bioprinter”) to an undisclosed, forward-deployed location for ten weeks of bioprinting and experimentation in a desert environment, led by LTC Jason Barnhill of the United States Military Academy's Department of Chemistry and Life Science (West Point). The team intends to create a number of experimental prints, including plastic medical models, mesenchymal stem cells, and next-gen wound bandages.
This project is a step towards bringing next-generation critical care close to the warfighter. Bioprinting a variety of wound-healing biologics, bandages, stents, and bandage/biosensors, on demand and at or near the point-of-care, is an example that is expected to improve healing and survival rates of the warfighter. Point-of-care bioprinting is also expected to provide significant advantages in soldier care and military applications, reducing expensive and wasteful logistics, warehousing, refrigeration, and shipping. Bioprinting only what the soldier needs, where it is needed, and when it is needed, is expected to improve outcomes and reduce overall costs of advanced medicine for the warfighter.
For Free Info Visit Here